B. Riley analyst Kyle Bauser lowered the firm’s price target on Performant Financial (PFMT) to $7 from $8 and keeps a Buy rating on the shares post the Q3 report. The company reiterated fiscal 2024 healthcare sales and adjusted EBITDA guidance while reducing nonhealthcare sales expectations, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFMT: